New Psychoactive Substances and Psychosis
There are increasing numbers of case reports detailing adverse side effects associated with the use of new psychoactive substance (NPS), in particular synthetic cannabinoids. This project will look at the rate of relapse in patients with psychosis who have a mention of NPS use in their records and compare this to the relapse rate of patients with psychosis and no mention of NPS use.